title: Apoptotic cardiomyocyte death in fatal myocarditis.
abstract: Acute myocarditis is often a self-limited process with a good outcome. Experimental animal studies have found that cardiomyocyte apoptosis occurs in severe forms of myocarditis. We studied whether cardiomyocyte apoptosis plays a role in the development of fatal acute human myocarditis. Myocardial autopsy samples from subjects who died of acute myocarditis in Finland between 1970 and 1998 were studied. Thirty-three of these cases(16 men and 17 women; 45 +/- 6 years old) were randomly selected for this study. All cases fulfilled the histopathologic Dallas criteria for myocarditis. Eight subjects who had died accidentally served as controls. Apoptotic DNA fragmentation (terminal transferase-mediated DNA nick end labeling) and activation of caspase-3 (immunohistochemistry) were detected. The mode of death was determined retrospectively from all available clinical data. In fatal myocarditis, large amounts of cardiomyocytes showed apoptotic DNA fragmentation or contained active caspase-3 (2.0 +/- 0.3% and 2.8 +/- 0.4%, respectively). In the controls, few apoptotic cardiomyocytes were found (0.008 +/- 0.003% by terminal transferase-mediated DNA nick end labeling and 0.009 +/- 0.003% by detection of active caspase-3, p <0.001 vs myocarditis). The amount of apoptosis did not correlate with the age or gender of the cases, recognized viral etiology, histologic features, or duration of disease. However, more apoptotic cardiomyocytes were detected in the subjects who had myocarditis and had died of heart failure (n = 18) than in those who had myocarditis and died suddenly of cardiac arrest (n = 15; 2.6 +/- 0.4% vs 1.1 +/- 0.2%, p <0.001). In conclusion, cardiomyocyte apoptosis is a common mechanism of myocardial damage in severe acute human myocarditis. Moreover, higher rates of cardiomyocyte apoptosis are associated with the development of fatal heart failure in acute myocarditis.
authors.affiliation: Department of Anatomy, Turku Graduate School of Biomedical Sciences, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland. ville.kyto@utu.fi
authors.forename: Ville
authors.initials: V
authors.lastname: Kytö
authors.forename: Antti
authors.initials: A
authors.lastname: Saraste
authors.forename: Pekka
authors.initials: P
authors.lastname: Saukko
authors.forename: Véronique
authors.initials: V
authors.lastname: Henn
authors.forename: Kari
authors.initials: K
authors.lastname: Pulkki
authors.forename: Tytti
authors.initials: T
authors.lastname: Vuorinen
authors.forename: Liisa-Maria
authors.initials: LM
authors.lastname: Voipio-Pulkki
mesh_terms: D000704:Analysis of Variance; D017209:Apoptosis; D016022:Case-Control Studies; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D053938:DNA Fragmentation; D005260:Female; D005387:Finland / Q000453:epidemiology; D006801:Humans; D020287:In Situ Nick-End Labeling; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000401:mortality / Q000473:pathology*; D032383:Myocytes, Cardiac / Q000201:enzymology / Q000473:pathology*
chemical_list: C505407:CASP3 protein, human; D053148:Caspase 3; D020169:Caspases